Tenders

Humaanfibrinogeeni ostmine

Closed

Submission Deadline Has Passed

This tender's submission deadline has passed and is no longer accepting applications. The information below is kept for reference purposes.

Browse Active Tenders
Deadline
Expired
October 13, 2025
Contract Details
Category
Supplies
Reference
301043
Value
€29,000
Location
Estonia
Published
October 03, 2025
CPV Code
Project Timeline

Tender Published

October 03, 2025

Deadline for Questions

October 06, 2025

Submission Deadline

October 13, 2025

Tender Opening

October 13, 2025

Win ProbabilityPRO
🔒
Upgrade to Professional
See your estimated win probability based on historical data.
Upgrade to Professional →
Buyer IntelligencePRO
🔒
Unlock Buyer Intelligence
See spending patterns, preferred procedures, and more.
Upgrade to Professional →
Sector InsightsPRO
🔒
Unlock Sector Insights
See average winning prices, competition levels, and market trends.
Upgrade to Professional →
Budget
€29,000
Duration
12 months
Location
Estonia
Type
Supplies
Market Benchmark
Avg. Winning Price
€92,792
Avg. Bids
2.2
Competition
Low
SME Winners
86%
3,220 tenders analyzed

Original Tender Description

Käesoleva hanke tulemusena sõlmitakse eduka pakkujaga leping Aktsiaseltsile Rakvere Haigla humaanfibrinogeeni ostuks ja tarnimiseks 12 kuuks vastavalt hanke alusdokumentidest tulenevatele tehnilistele tingimustele.
Electronic Submission

Risk Analysis

Please log in to use risk analysis.

Login

Win Strategy

Please log in to access winning strategy recommendations.

Login

Competitors

Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.

Login

Requirements & Qualifications

20 requirements across 5 categories

Submission (5)
Mandatory (4)
Compliance (4)
Technical (4)
Financial (3)
SUBMISSION REQUIREMENTS5
--Complete and submit ESPD (version 2.0 extended) electronically via e-procurement system; no paper originals requested at this stage
--Enter the exact unit price in the dedicated field of the ESPD Annex 1; any discrepancy between ESPD and e-form price will invalidate the bid
--Confirm acceptance of the draft one-year supply contract (Lisa 2) and all delivery/incoterms stated therein
MANDATORY QUALIFICATIONS4
--Be legally registered in an EU Member State; Russian or Belarusian firms are automatically excluded
--Hold valid wholesale distribution authorisation (GDP) for medicinal products
--Possess marketing authorisation or parallel-import licence for human fibrinogen in Estonia (ATC B02BB01) or be able to supply under hospital exemption with documented regulatory approval
COMPLIANCE REQUIREMENTS4
--Certify that the product and the supplying entity are not subject to any EU/international sanctions
--Guarantee cold-chain (2–8 °C) transport and provide temperature-monitoring documentation for every shipment
--Supply Estonian or English Summary of Product Characteristics (SPC) within 72 h upon hospital request
TECHNICAL REQUIREMENTS4
--Deliver human fibrinogen 1 g powder + solvent per vial, hospital/pharmaceutical grade, shelf-life ≥ 75 % at time of delivery
--Accept single-vial minimum order quantities; no minimum monthly volume commitment from buyer
--Provide fixed unit price (in EUR, 2 decimals, ex-VAT) that remains unchanged for the entire 12-month contract period
FINANCIAL REQUIREMENTS3
--Bid a single all-inclusive unit price (ex-VAT) in the ESPD Annex 1/e-procurement form; price is the sole award criterion (lowest price wins)
--Ensure the quoted unit price does not exceed 80 EUR per vial (ceiling indicated in evaluation criteria)
--No financial turnover or minimum annual revenue thresholds disclosed—await full tender documents for any additional economic-financial capacity proof

Requirements Preview

Sign up to view complete requirements and analysis

Documents

6 documents available with AI summaries

VastavustingimusedPDF
301043_vastavustingimused.pdf -- 6.1 KB

One-sentence business summary
“Rakvere Hospital is running a 12-month mandatory-supply tender for human fibrinogen (no Russian/Belarusian firms allowed) where the only gate-to-bid is completing Annex 1 with the exact unit price (€, 2 decimals, ex-VAT) that matches the e-procurement form and certifying the product is not under international sanctions—no further technical/quality criteria disclosed—so any EU-sourced fibrinogen supplier that can deliver steady hospital-grade stock for a year and meet these simple compliance checks should bid.”

Hindamiskriteeriumid ja hinnatavad näitajadPDF
301043_hindamiskriteeriumid.pdf -- 3.2 KB

Rakvere Haigla otsib 12 kuuks tarnijat humaanfibrinogeenile, kus ainsaks hindamiskriteeriumiks (100 %) on ilma käibemaksuta eurodes esitatav MADALAIM ÜHIKHIND (ühik 80 EUR); tehnilised nõuded on kirjas Lisa 1-s, vene või valgevene ettevõtjaid ei lubata ja hanke võidab odavaim aus pakkumus.

Hankepass täiendatavate selgitustegaPDF
301043_hankepass_taiendavate_selgitustega.pdf -- 37.7 KB

Rakvere Hospital seeks a 12-month supplier of human fibrinogen (mandatory pharmaceutical-grade product) and will exclude any bidder located in Russia or Belarus; no detailed technical, financial or experience criteria are disclosed in this ESPD-only notice, so firms should await full tender documents to confirm compliance before deciding to bid.

Lisa 1 - tehniline kirjeldus/detailse hinnapakkumuse esitamise vormDOC
Lisa 1 - Tehniline kirjeldus (RH 301043).docx -- 42.6 KB

Rakvere Hospital seeks a 12-month supply (70–80 vials) of human fibrinogen (ATC B02BB01) 1 g powder + solvent, requiring mandatory Estonian/English SPC on request, 72-hour delivery to Rakvere, cold-chain compliance, 1-piece minimum orders, fixed unit price for the full contract period, and bidders must not be located in Russia or Belarus.

Lisa 2 - Hankelepingu projektDOC
Lisa 2 - Hankelepingu projekt (RH 301043).doc... -- 43.7 KB

One-year (mandatory) supply contract for human fibrinogen to Rakvere Hospital; bidders must be EU-based (Russian/Belarusian firms excluded) and will be evaluated on compliance with the technical requirements stated in the procurement documents.

Pakkumuste esitamise ettepanek/hanke üldtingimusedDOC
Pakkumuste esitamise ettepanek (RH 301043).do... -- 40.8 KB

Rakvere Hospital (AS) is running a simplified, 12-month open procurement for human fibrinogen (medicines CPV) with mandatory delivery terms set out in the tender documents, open only to suppliers not located in Russia or Belarus, and the buyer may convert the procedure to a negotiated process or reject all offers.

Documents Preview

Sign up to view document summaries and analysis

Analysis Pending

Quality analysis for this tender is being processed. Please check back shortly.

Add to Pipeline